← All companies
CRISPR Therapeutics AG
CRSP - CIK 0001674416
Market cap$4.82 B
Rank#1414
SEC filings837
The table below shows CRISPR Therapeutics AG's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $423.31M | $286.50M | $193.62M | $235.18M | $225.67M | $484.47M |
| Short-term investments | $2.02B | $1.63B | $1.53B | $1.62B | $1.71B | $1.52B |
| Receivables | - | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.